Cytometric evaluation of intracellular IFN-γ and IL-4 levels in thyroid follicular cells from patients with autoimmune thyroid diseases

Thyroid Research

Volumn 4, Issue 1, 2011, Pages

  Bossowski, Artur ^a   Harasymczuk, Jerzy ^b   Moniuszko, Anna ^a   Bossowska, Anna ^c   Hilczer, MacIej ^d   Ratomski, Karol ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^c Division of Cardiology   (Poland)

^d Medical University   (Poland)

Author keywords

cytokines; disease; Graves; Hashimoto's thyroiditis; thyrocytes

Indexed keywords

EID: 80053990310     PISSN: None     EISSN: 17566614     Source Type: Journal    
DOI: 10.1186/1756-6614-4-13     Document Type: Article

References (20)

1. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Mosmann TR, Coffman RL, Annu Rev Immunol 1989 7 145 173 10.1146/annurev.iy.07.040189.001045 2523712 (Pubitemid 19138011)
2. Intrathyroidal cytokine expression profiles in autoimmune thyroiditis. Paschke R, Schuppert F, Taton M, Velu T, J Immunol 1994 141 309 315 (Pubitemid 24199330)
3. Analysis of cytokine gene expression in Graves' disease and multinodular goitre. Watson PF, Pickerill AP, Davies R, Weetman AP, Clin Endocrinol Metab 1994 79 355 360 10.1210/jc.79.2.355 (Pubitemid 24256517)
4. Intra-thyroidal cytokine gene expression in Hashimoto's thyroiditis. Ajjan RA, Watson PF, McIntosh RS, Weetman AP, Clin Exp Immunol 1996 105 523 528 10.1046/j.1365-2249.1996.d01-784.x 8809144 (Pubitemid 26297900)
5. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Nanba T, Watanabe M, Inoue N, Iwatani Y, Thyroid 2009 5 495 501
6. Thyrotropin stimulates specifically the expression of the autoantibody binding domains of the thyroperoxidase molecule. Rasmussen AK, Feldt-Rasmussn U, Brandt M, Hartoft-Nielsen ML, Carayon P, Buschard K, Autoimmunity 1999 29 323 331 10.3109/08916939908994752 10433088 (Pubitemid 29237587)
7. Application of mAbs for identification of antigen regions of human thyroid peroxidase in adolescents with Graves' disease and non-toxic multinodular goiter by flow cytometry. Bossowski A, Stasiak-Barmuta A, Czarnocka B, Urban M, Dadan J, Autoimmunity 2005 38 605 11 10.1080/08916930500315084 16390813 (Pubitemid 43101943)
8. Fas/Fas ligand-driven T cell apoptosis as a conseqence of ineffective thyroid immunoprivilege in Hashimoto's thyroiditis. Stassi G, Todaro M, Bucchieri F, Stoppacciaro A, Farina F, Zummo G, Testi R, De Maria R, J Immunol 1999 162 263 267 9886394 (Pubitemid 29018928)
9. The thyroid and autoimmunity. Lichiardopol C, Moa M, Rom J Intern Med 2009 47 207 15 20446435
10. The pathogenesis of Graves' disease. McIver B, Morris JC, Endocrinol Metab Clin North Am 1998 27 73 89 10.1016/S0889-8529(05)70299-1 9534029 (Pubitemid 28144955)
11. Fas-FasL in Hashimoto's thyroiditis. Stassi G, Zeuner A, Di Liberto D, Todaro M, Ricci-Vitiani L, De Maria R, J Clin Immunol 2001 21 19 23 10.1023/A:1006732713634 11321234 (Pubitemid 32281583)
12. Cellular immune responses in autoimmune thyroid disease. Weetman AP, Clinical Endocrinology 2004 61 405 413 10.1111/j.1365-2265.2004.02085.x 15473869 (Pubitemid 39388475)
13. Contrasting roles of IFN-gamma in murine models of autoimmune thyroid diseases. Fang Y, Yu S, Braley-Mullen H, Thyroid 2007 17 989 94 10.1089/thy.2007.0261 17910526 (Pubitemid 350071603)
14. Long-term outcome of interferon - induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment. Carella C, Mazziotti G, Morisco F, Manganella G, Rotondi M, Tuccillo C, Sorvillo F, Caporaso N, Amato G, Journal of Clinical Endocrinology and Metabolism 2001 86 1925 1929 10.1210/jc.86.5.1925 11344186 (Pubitemid 32472899)
15. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2). Phenekos C, Vryonidou A, Gritzapis AD, Baxevanis CN, Goula M, Papamichail M, Euroimmunomodulation 2004 11 209 13 10.1159/000078438 (Pubitemid 38916092)
16. Lack of association between interleukin-4 gene polymorphisms and autoimmune thyroid diseases amongst Taiwanese Chinese. Chen RH, Chang CT, Wang TY, Chen CC, Tsai CH, Tsai FJ, Endocrine 2007 32 170 4
17. Association analysis of polymorphisms in IL-3, IL-4, IL-5, IL-9 and IL-13 with Graves' disease. Zhu W, Liu N, Zhao Y, Jia H, Cui B, Ning G, J Endocrinol Invest 2010 03 22
18. Gene polymorphisms of interleukin-4, interleukin-10 and transforming growth factor-beta in Graves' disease. Khalilzadeh O, Anvari M, Momen-Heravi F, Esteghamati A, Rashidi A, Mahmoudi M, Nikbin B, Amirzargar A, Clin Exp Med 2010 10 123 8 10.1007/s10238-009-0078-5 19882211
19. Levels of cytokines and thyroid autoantibodies in Omani patients with Graves' disease. Alnaqdy A, Al-Maskari M, Br J Biomed Sci 2007 64 164 7 18236738
20. Autoimmune thyroid disease: Newmodels of cell death in autoimmunity. Stassi G, De Maria R, Nat Rev Immunol 2002 2 195 204 10.1038/nri750 11913070 (Pubitemid 37328766)